(VIANEWS) – Shares of Bionano Genomics (NASDAQ: BNGO) fell 8.06% to $3.31 at 10:12 EST on Tuesday, following the last session’s downward trend. NASDAQ is rising 0.62% to $13,128.05, after two successive sessions in a row of gains. This seems, up to now, a somewhat up trend exchanging session today.

Bionano Genomics’s last close was $3.60, 43.49% below its 52-week high of $6.37.


Today’s last reported volume for Bionano Genomics is 3191580 which is 59.7% below its average volume of 7920646.

Bionano Genomics’s Sales

Bionano Genomics’s sales growth is 62.9% for the ongoing quarter and 59.8% for the next. The company’s growth estimates for the current quarter and the next is a negative 28.6% and a negative 28.6%, respectively.

Bionano Genomics’s Revenue

Year-on-year quarterly revenue growth grew by 57.9%, now sitting on 17.98M for the twelve trailing months.


Bionano Genomics’s last week, last month’s, and last quarter’s current intraday variation average was 17.31%, 4.52%, and 5.76%, respectively.

Bionano Genomics’s highest amplitude of average volatility was 17.31% (last week), 7.39% (last month), and 5.76% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Bionano Genomics’s stock is considered to be oversold (<=20).

Bionano Genomics’s Stock Yearly Top and Bottom Value

Bionano Genomics’s stock is valued at $3.31 at 10:12 EST, way below its 52-week high of $6.37 and way above its 52-week low of $1.16.

Bionano Genomics’s Moving Average

Bionano Genomics’s value is way above its 50-day moving average of $1.56 and way above its 200-day moving average of $2.70.

More news about Bionano Genomics (BNGO).